ATIIW - Archimedes Tech SP... Stock Analysis | Stock Taper
Logo
Archimedes Tech SPAC Partners II Co. Warrant

ATIIW

Archimedes Tech SPAC Partners II Co. Warrant NASDAQ
$0.42 -3.17% (-0.01)

Market Cap $12.46 M
52w High $0.53
52w Low $0.41
P/E 0
Volume 1.45K
Outstanding Shares 29.59M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q4-2025 $0 $318.68K $2.07M 0% $0.07 $-318.68K
Q3-2025 $0 $159.84K $2.4M 0% $0.08 $-159.84K
Q2-2025 $0 $130.36K $2.36M 0% $0.08 $-130.36K
Q1-2025 $0 $146.66K $1.16M 0% $0.06 $-146.66K
Q3-2024 $0 $13K $-55.7 0% $-0 $-55.7

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q4-2025 $1.36M $241.35M $8.19M $233.16M
Q3-2025 $1.41M $239.27M $8.18M $231.09M
Q2-2025 $1.76M $236.9M $8.21M $228.69M
Q1-2025 $1.86M $234.55M $8.22M $226.33M
Q3-2024 $0 $337.31K $368.01K $-30.7K

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q4-2025 $2.07M $-45.07K $-231.15M $-1.28K $-46.35K $-45.08K
Q3-2025 $2.4M $-344.58K $231.15M $-11.16K $-355.74K $-344.58K
Q2-2025 $2.36M $-95.39K $0 $-2.93K $-98.31K $-95.39K
Q1-2025 $1.16M $-254.01K $-231.15M $233.27M $1.86M $-254.01K
Q3-2024 $-55.7K $0 $0 $0 $0 $0

5-Year Trend Analysis

A comprehensive look at Archimedes Tech SPAC Partners II Co. Warrant's financial evolution and strategic trajectory over the past five years.

+ Strengths

Key strengths include a large cash position relative to obligations, no financial debt, and a simple, transparent balance sheet, all of which provide flexibility to execute a deal. On the qualitative side, the sponsors bring experience in technology and prior SPAC transactions, with a clear focus on high‑growth areas like AI and cloud, which could create upside if they secure a strong target.

! Risks

Major risks center on the absence of an operating business: no revenue, negative operating and free cash flow, and accounting equity that is already negative. The structure is fully reliant on non‑operating gains and previously raised capital, and there is meaningful execution risk around finding a suitable target, negotiating fair terms, and navigating a more skeptical SPAC and regulatory environment. For warrant holders specifically, there is additional risk around dilution, deal quality, and the possibility the warrants expire worthless if no successful combination occurs.

Outlook

The outlook is highly uncertain and essentially binary: outcomes will depend almost entirely on the quality of the eventual merger partner and the post‑deal performance of that business. Until a transaction is announced, the financials mainly describe a temporary cash shell slowly using funds for search and overhead. Once a target is named, the focus will quickly shift from SPAC mechanics to the underlying company’s growth prospects, competitive position, and ability to generate sustainable cash flow, which will ultimately determine the long‑term relevance of all these early‑stage figures.